SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Zynerba Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline – ZYNE  

NEW YORK, Dec. 06, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Zynerba Pharmaceuticals, Inc. (Zynerba or the Company) (NASDAQ: ZYNE) and certain of its officers.